Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and Craniofacial Dysarthrosis

bromodeoxyuridine has been researched along with Craniofacial Dysarthrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basilico, C; Bellosta, P; Mansukhani, A; Sahni, M1
Ferm, VH1

Other Studies

2 other study(ies) available for bromodeoxyuridine and Craniofacial Dysarthrosis

ArticleYear
Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    The Journal of cell biology, 2000, Jun-12, Volume: 149, Issue:6

    Topics: Acrocephalosyndactylia; Alkaline Phosphatase; Animals; Apoptosis; Bromodeoxyuridine; Calcification, Physiologic; Cell Differentiation; Cell Division; Cell Line; Craniofacial Dysostosis; DNA Fragmentation; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Histocytochemistry; Mice; Mice, Transgenic; Osteoblasts; Point Mutation; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Signal Transduction; Transfection

2000
The rapid detection of teratogenic activity.
    Laboratory investigation; a journal of technical methods and pathology, 1965, Volume: 14, Issue:8

    Topics: Abnormalities, Drug-Induced; Animals; Bromodeoxyuridine; Colchicine; Craniofacial Dysostosis; Cricetinae; Dwarfism; Female; Heart Defects, Congenital; Microcephaly; Pregnancy; Pregnancy, Animal; Spinal Dysraphism; Trypan Blue; Vitamin A

1965